Chronic cough and sputum production are common features of chronic obstructive pulmonary disease (COPD) and have a significant impact on exacerbation frequency and quality of life. Despite this, techniques to assist with removal of sputum from the airway do not have a well-defined role in COPD management. Clinical trials of airway clearance techniques (ACTs) in COPD have shown mixed results with little evidence of long-term benefit. However many studies have failed to account for the heterogeneity of COPD lung disease, particularly with regard to the presence of bronchiectasis. Analysis of short-term studies suggests that there may be a cohort of patients who will benefit from prescription of a sputum clearance regimen. This review proposes a physiological rationale for the use of ACTs in COPD, taking into consideration the presence of bronchiectasis, the amount of sputum produced, the degree of airflow obstruction and the presence of decreased lung elastic recoil. The selection of an optimal ACT for individuals with COPD should take into account its effects on lung vloumes, expiratory flow and dynamic airway compression. Care should be taken to avoid airway collapse during forced expirations in patients with reduced lung recoil pressure; positive expiratory pressure therapy or autogenic drainage may prove effective in this patient group. The acceptability of ACTs to patients should also be considered, especially where long-term adherence is required. Future research should focus on more appropriate matching of the physiological effects of individual ACTs to the pathophysiology of lung disease in COPD. Chronic Respiratory Disease 2006; 3: 83-91
Introduction
Chronic cough and sputum production are key features of chronic obstructive pulmonary disease (COPD).1
These symptoms, which occur as a result of mucus hypersecretion and ciliary dysfunction, play an important role in the clinical course of COPD. Daily cough and sputum production are predictive of frequent COPD exacerbations2 and those patients who have frequent exacerbations have worse health-related quality of life and a more rapid rate of deterioration in health status. 3 Airway clearance techniques (ACTs) involve the external application of forces to enhance removal of sputum from the airway. Assumptions underlying the use of ACTs are that mucus hypersecretion in COPD results in further mucosal injury4 and contributes to airflow obstruction,5 suggesting a role for airway clearance in preserving pulmonary function over time. A recent consensus statement describes ACTs as a 'cornerstone' of management for adults with cystic fibrosis (CF),6 a disease where mucus hypersecretion and bronchiectasis are almost universal features. To date, ACTs have not found a similar role in COPD.7 A Cochrane review that included seven trials of 'bronchopulmonary hygiene physical therapy' in COPD and bronchiectasis found some evidence to support increased sputum production and isotope clearance from the lung, primarily from trials involving subjects with bronchiectasis. 8 However, due to the lack of demonstrable clinical benefits, the authors concluded that there was insufficient evidence to support or refute the use of ACTs in these patient groups. Likewise, a consensus statement on the treatment of acute exacerbations of COPD has concluded that 'chest physiotherapy (does) not appear to be of benefit', based on the results of three randomized controlled trials and one observational study.9 The small number of studies included in these reviews must necessarily limit the strength of conclusions that can be drawn. However, it seems likely that ACTs are not universally beneficial in COPD.
It is well recognized that COPD is a heterogeneous disease, including patients with a variety of pathological features.10 Bronchiectasis can be detected in 29-50% of patients with COPD4'11 and those patients with lower lobe bronchiectasis are more likely to have lower airway bacterial colonization and take longer to recover from an exacerbation. 4 In contrast, patients with higher emphysema scores are less likely to report increased sputum volume during exacerbations.4 Such differences between 'wet' and 'dry' COPD may determine whether ACTs are required. There is also some evidence that individual pathophysiology, including degree of airflow obstruction'2 and lung elastic recoil pressure'3 influences response to ACTs in COPD. Unfortunately, there are no guidelines which incorporate these factors into clinical decisionmaking.
As yet, there has been no evidence that a single airway clearance regimen is effective in COPD. It seems likely that a more complex approach is required, taking into account the heterogeneity of COPD and the specific mechanisms of different ACTs. This review proposes a more sophisticated rationale for the prescription of ACTs in COPD.
Physiological basis of mucus clearance
In patients with COPD, chronic inflammation leads to mucus hypersecretion and ciliary dysfunction.' When mucociliary transport is impaired, a secondary clearance mechanism known as two-phase gas liquid flow (TPGLF) plays an essential role in removing mucus from the lung.'4 Airway clearance techniques make use of TPGLF to move mucus towards the mouth, from where it can be expectorated.
When air flows over a thick mucus layer, a shear force is developed on the surface of the liquid layer in proportion to the square of the airflow velocity. When the shear force exceeds the surface tension in the mucus layer, the mucus will begin to move in the direction of the airflow. In model airways, mucus flow is thus greatest when expiratory airflow velocity is high.'5 The effects of TPGLF are enhanced when gravity is available to assist.14 This principle is used advantageously during airway clearance with gravityassisted drainage. '6 During expiration, airway diameter reduces with decreasing lung volume. Maximal airflow velocity is inversely proportional to the diameter of the airway. '4 Decreasing airway diameter at low lung volumes during expiration will thus facilitate mucus transport by TPGLF, especially in the central airways where total airway diameter is smaller than in the peripheral airways.
The effects of reduced airway diameter are enhanced by dynamic compression of airways during forced expiratory manoeuvres, an effect which is exploited during ACTs such as the forced expiration technique (FET).1Y During a forced expiration, the driving pressure which produces expiratory flow is the sum of the elastic recoil pressure of the lungs and the pleural pressure.'8 The pressure in the airway will decrease gradually from the peripheral airways to the central airways due to frictional and convective acceleration pressure loss. There is a point in the airway known as the equal pressure point (EPP), where intrabronchial pressure is equal to the surrounding pleural pressure. In the segment of the airway upstream (toward the alveoli) from the EPP, intrabronchial pressure is higher than pleural pressure and no dynamic airway compression can occur. However downstream (toward the mouth) from the EPP, pleural pressure exceeds intrabronchial pressure and thus dynamic compression can take place. '8 The site of the EPP can be altered by variations in expiratory force and lung volume.'9 A higher expiratory force leads to a higher pleural pressure and thus to a shift of the EPP in the direction of the alveoli. Conversely, if the forced expiration is commenced from a higher lung volume, the elastic recoil pressure will be higher resulting in a shift of the EPP toward the mouth. Alterations in lung volume and expiratory force are used during ACTs, frequently with the aim of moving the EPP toward the alveoli and thus enabling greater clearance of peripheral secretions.20 '21 The presence of airflow obstruction affects the location and degree of dynamic airway compression. When severe airflow obstruction is present there is likely to be greater loss of driving pressure during expiration, resulting in a shift of the EPP toward the alveoli. Similarly, a loss of elastic recoil of lung tissue, as is a feature of COPD, also results in a shift of the EPP upstream.19 The peripheral airways are more compliant than the central airways and thus dynamic compression may result in complete airway collapse. The effectiveness of mucus transport by forced expiration is thus reduced in COPD patients who have decreased pulmonary elastic recoil pressure. 22 Chronic Respiratory Disease Where complete airway collapse or expiratory flow limitation is present, increased pressure at the mouth could be used to splint open the airways and enhance expiratory flow.23 Increased intrabronchial pressure is thought to move the EPP in the direction of the mouth, thus dilating closed airways. Airway clearance techniques that increase flow resistance at the mouth, such as positive expiratory pressure therapy, may facilitate TPGLF through the splinting of otherwise collapsible airways.24 '25 A physiological rationale for the use of ACTs in COPD must therefore include the effects of alterations in lung volume, expiratory force, body position and mouth pressure on mucus clearance. The effectiveness of individual ACTs in COPD and evidence supporting their mechanism of action will be discussed in the following section.
Comparison of airway clearance techniques in COPD
Conventional chest physiotherapy Conventional chest physiotherapy (CCPT) may include any combination of gravity-assisted drainage, percussion, vibrations and directed coughing.26 Randomized crossover trials involving subjects with COPD have demonstrated that CCPT increases mucus transport compared with both no treatment27'28 and cough alone.29 However, other authors have reported that directed coughing is equally effective. 30 The effect of CCPT on pulmonary function is unclear. Descriptive trials have reported decreased airways obstruction following CCPT,31'32 although other authors have found no effect on pulmonary function. 33'34 It is likely that some of the disparity in the reported effects of CCPT results from differences in patient populations. Those studies where the effectiveness of CCPT has been demonstrated have included subjects who produce a large volume of sputum,27-29,31 usually defined as greater than 30 mL/day. This criterion has resulted in few subjects with COPD being included, with many subjects having a diagnosis of bronchiectasis. In studies where the expectorated sputum volume is small to moderate a positive effect has not been demonstrated.3033 This suggests that the use of CCPT in COPD should be confined to those patients who produce copious respiratory secretions.
Some authors have attempted to isolate the contributions of the various components of CCPT. Gravity-assisted drainage (GAD), also known as postural drainage, involves the use of specific body positions to enhance mucociliary clearance. 35 Sutton and colleagues28 found that the addition of GAD to forced expirations increased the amount of expectorated sputum, although the validity of this outcome measure has been questioned."7 Gravity-assisted drainage alone has been reported to have no effect on pulmonary func-tion36 and was less effective in promoting mucociliary clearance than either exercise or directed coughing. 30 Several studies have reported unpleasant sideeffects of GAD. In a survey of 50 patients who were prescribed regular GAD, some of whom had COPD, 10% of subjects reported pain and 24% reported discomfort during GAD.37 Subjects have reported aching shoulders and hips during GAD,38 while GAD is reported to be significantly less comfortable than other ACTs and may not be possible in those with significant osteoarthritis.28
Gravity-assisted drainage may not be tolerated in some patients with COPD due to dyspnoea.34 This symptom may be linked to position-related changes in lung volumes. Marini and colleagues12 demonstrated that in subjects with normal lungs, functional residual capacity (FRC) decreased by 30% on moving from sitting to supine or sidelying with head-down tilt (HDT). In contrast, in subjects with moderate COPD the FRC was unchanged and in severely obstructed patients the FRC increased in supine compared to the sitting position. The authors postulated that maintenance of FRC in supine and HDT reflected a position-related increase in gas trapping. The increase in FRC in supine and HDT seen in subjects with severe COPD may reflect dynamic hyperinflation in order to maintain adequate expiratory flow, as has been demonstrated during exercise.39 This would have adverse effects on work of breathing40 and may explain the increase in dyspnoea in HDT positions.'2 The effects of GAD on lung volumes and dyspnoea will thus vary according to the degree of airflow obstruction in COPD.
Gravity-assisted drainage has been associated with increased episodes of gastro-oesophageal reflux (GOR) in normal subjects, patients with acute respiratory infections and chronic suppurative lung disease.4144 To date this association has not been documented in COPD. There may be an increased prevalence of both symptomatic and silent GOR across the range of disease severity in COPD.45'46 Given the respiratory consequences of GOR,47 the potential for this adverse effect of GAD should be considered.
It has been suggested that percussion is a useful addition to GAD in patients with copious respiratory secretions.48 However, studies in COPD have failed to show any additional benefit of percussion on tracheobronchial clearance when GAD is used in patients with large amounts of sputum.49'50 Adverse effects of percussion have been documented in hospitalized COPD www.CRDjournal.com subjects with minimal secretions, including reduced PaO2 persisting for 30 minutes following treatment in acutely ill patients5l and a reduction in FEVy following treatment in patients recovering from acute exacerbations of chronic bronchitis.33'52 These negative effects were not seen in patients with copious respiratory secretions.51 Vibration of the chest wall during CCPT has little evidentiary support, with studies failing to find any effect on tracheobronchial clearance53 or any additional benefit over GAD and percussion.54 At present, no convincing role for percussion and vibrations has been demonstrated in COPD.
Active cycle of breathing technique
The Active Cycle of Breathing Technique (ACBT) includes breathing control (gentle, relaxed breathing around tidal volume), thoracic expansion exercises and the forced expiration technique (FET). Forced expirations occur without closure of the glottis, commencing from mid-lung volume and continuing towards residual volume. The ACBT may be combined with GAD or percussion.26
Of the various components of the ACBT, only the FET has been systematically evaluated. It has been reported that the FET enhances tracheobronchial clearance, whereas directed coughing is no more effective than a control period.28 Other authors have shown that FET and cough are equally effective in promoting clearance from the whole lung in COPD, both where there is copious sputum production55 and in those who produce minimal secretions.13'56 There was no relationship between effective clearance and peak flow during FET,56 suggesting that this ACT may be appropriate for those who cannot generate high flow rates due to severe airflow obstruction. This may contribute to the effectiveness of the ACBT in very unwell patients, where it may decrease the duration that noninvasive ventilation (NIV) is required for acute hypercapnic respiratory failure in COPD.57
Van der Schans and colleagues have shown that the effects of the FET may vary according to the underlying pathophysiology in COPD.13 Clearance of radiolabelled secretions was compared in a group of patients with decreased elastic lung recoil ('emphysema' group) and a group with normal elastic recoil ('chronic bronchitis' group). Both groups had similar FEVI and expectorated a similar amount of sputum, however the emphysema group had higher compliance and more hyperinflation. Both FET and cough enhanced mucus clearance in the lung periphery in subjects with chronic bronchitis; however there was no effect of either technique in subjects with emphysema. This Chronic Respiratory Disease lack of effectiveness in emphysema may occur due to complete collapse of highly compliant airways during forced expiration.58 In these circumstances, alternative ACTs that avoid dynamic airway compression in peripheral airways may be required.
Comparison with other ACTs shows that the FET performed in sidelying produces a greater sputum volume in the hour after treatment than GAD and percussion. 59 It has also been demonstrated that more sputum is produced when the FET is combined with GAD than when it is performed in sitting.28 Overall, the available evidence suggests that the ACBT and/or FET are an effective means of increasing mucus transport in COPD, especially in patients with chronic bronchitis. No controlled data are available to assess the relative contribution of the components of the ACBT; however from a physiological and mechanistic perspective it seems likely that the FET is the crucial element of the technique.19
Positive expiratory pressure therapy Positive expiratory pressure therapy is defined as breathing with a positive expiratory pressure of 10-20 cmH2O. The technique employs a face mask and two one way valves with a variable resistor attached to the expiratory valve. The diameter of the resistor is individually determined for each patient to provide the required level of positive pressure during a slightly active tidal expiration. A treatment session consists of periods of breathing with PEP followed by the FET and cough.60
The theoretical rationale for the use of PEP therapy is that in the presence of small airway obstruction caused by secretion retention, the relative resistance to airflow in collateral channels will be reduced. The application of positive pressure to the airway will therefore allow an increased volume of air to accumulate behind the obstruction, and the pressure gradient across the sputum plug will force secretions centrally toward the larger airways, from where they can be expectorated.246' It is a widely used technique in CF, where PEP therapy in combination with the FET in upright sitting was shown to be superior to GAD and percussion for enhancing sputum clearance.24 A long-term randomized controlled trial has compared PEP combined with the FET to conventional breathing exercises and the FET in patients with chronic bronchitis.62 After 4-12 months the PEP group had significantly less cough and mucus production, fewer exacerbations and a trend toward better FEV1 compared to the control group. Another randomized controlled trial has shown that PEP can be used successfully in hypersecretive COPD patients receiving NIV for acute respiratory failure. Those that undertook a daily PEP session required an average of two days less NIV compared to the control group who undertook coughing alone. 63 The mechanism by which PEP therapy achieves these positive outcomes in COPD has yet to be confirmeda study comparing the short-term effects of PEP + FET and GAD + FET in subjects with chronic bronchitis found that GAD + FET improved mucus clearance whereas PEP + FET did not.64 However it is difficult to interpret this finding as the GAD treatment was of longer duration and incorporated more forced expirations. Another study comparing the short-term effects of GAD + FET, PEP + FET and a rest period showed that mucus clearance during GAD + FET was significantly higher than during PEP + FET. 38 In this study there was no difference between the regimens in the number of coughs and forced expirations. Both ACTs resulted in significantly greater sputum clearance than the control period. Patients thought the two methods were equally effective but most preferred PEP as a treatment, a factor which may have implications for adherence to regular therapy.
A variation of PEP therapy is the High-pressure PEP (HiPEP) technique. 25 Cycles of PEP breathing are followed by inhalation to total lung capacity, a forced expiratory manoeuvre against the resistor followed by coughing at low lung volume. Sustained expiratory pressures usually range between 40 and 100 cmH2O. The physiological rationale for HiPEP is to provide homogeneous emptying of lung units during expiration by splinting open collapsible airways.25 Air from hyperinflated lung units is thought to be moved into unobstructed and atelectatic lung units, resulting in mobilisation of mucus plugs and a decrease in gas trapping. As the degree of positive pressure diminishes towards the end of expiration, dynamic compression will occur at lower lung volume than normal, theoretically resulting in less airway collapse and more effective secretion clearance. To our knowledge there are no studies of patients using HiPEP therapy in COPD. Stabilisation of airways during forced expirations and coughing may prove to be a useful adjunct to airway clearance therapy in some patients with COPD. However, the development of sustained, high expiratory pressures requires generation of large respiratory muscle forces and this may be beyond the capabilities of severely unwell or exhausted patients.60
Oscillating devices Three types of oscillating devices are available. Oscillating PEP devices, such as the Flutter® (Scandipharm, Birmingham, AL), Comet® (Pari Respiratory Equipment, Midlothian, VA) or Acapella® (DHD Healthcare, Wampsville, NY), deliver an oscillating PEP effect in a similar manner to PEP techniques. Thoracic oscillation, such as high frequency chest wall oscillators, provides oscillation directly to the chest wall. Oral oscillation, such as oral high frequency oscillators, provides oscillation to the airways via the mouth.26
The Flutter® device generates controlled oscillating positive pressure during expiration in order to both loosen secretions and maintain airway patency, thus facilitating mucus expectoration. The frequency of oscillations obtainable from the Flutter® device during exhalation are considered to correspond to the spectrum of natural lung resonance (about 6-20 Hz), and can be modulated by changing the inclination of the device slightly up or down from its horizontal position.60
Ambrosino and co-workers undertook a short-term evaluation of oscillating positive expiratory pressure compared to GAD and percussion in patients with copious sputum production due to COPD, bronchiectasis, interstitial lung disease with bronchiectasis, chronic bronchitis and silicosis. In a randomized crossover trial conducted during an inpatient stay, the Flutter® device was found to be equally effective as GAD and percussion in terms of sputum expectoration, lung function and oxygen saturation.65 Another randomized crossover trial has compared the effects of the Flutter® device with both CCPT and forced expirations in the lateral position in patients hospitalized with an acute exacerbation of chronic bronchitis. All techniques were well tolerated and oxygen saturation and pulmonary function did not change significantly during and after treatments. Thirty minutes after the beginning of treatment, sputum expectoration increased significantly with all techniques, but during the hour after the end of treatment, it was significantly larger with Flutter® and forced expirations than with
GAD.59
A novel application of the Flutter® to enhance bronchodilator response in COPD has been described.66
Patients with severe stable COPD received oscillating PEP via the Flutter® device or a sham Flutter® device in random order on two successive days. Patients then inhaled ipratropium and salbutamol delivered by a metered-dose inhaler. After two hours, a significantly greater degree of bronchodilation was evident in those who had received the Flutter®, along with a small but statistically significant increase in a six-minute walk test distance compared to those who use the sham device. The improved bronchodilator response may be due to improved aerosol penetration in the distal www.CRDjournal.com airways as a result of mucus mobilization prior to inhalation of the drugs. In addition, by preventing airway collapse, the total cross-sectional airway calibre may be maintained for better distribution of inhaled aerosol. 66 The Comet® and the Acapella® operate on similar physiological principles to the Flutter®. It is known that the in vitro performance characteristics of the Acapella® are similar to those of the Flutter®,67 however, to date there have been no clinical comparisons in COPD. At the present time the efficacy of these two devices in COPD has not been adequately evaluated. There has been little investigation of oral and thoracic oscillators in COPD. A randomized crossover trial has compared oral high frequency oscillation (OHFO) to GAD and FET in patients with chronic bronchitis and copious sputum production.68 Significantly greater tracheobronchial clearance with GAD and FET compared to OHFO was demonstrated. This result may be due to the much larger number of forced expirations in the GAD and FET regimen. As it is generally considered that the FET is an essential component of all modem ACTs,60 the effectiveness of OHFO needs to be further evaluated in studies where the number of forced expirations is standardized across techniques.
Autogenic drainage
Autogenic drainage (AD) is a technique based on the principle of reaching the highest possible airflow in different generations of bronchi by controlled tidal breathing.69 By varying end-expiratory lung volume increased flow rates may be achieved in all the relevant generations of airways, allowing mucus to be cleared from all lung regions. Some evidence that greater expiratory flow rates are generated in smaller airways with AD compared to forced expirations is available from flow-volume curves in patients with CF.21 There has been little investigation of this technique in COPD.
Savci and colleagues70 conducted a randomized controlled trial comparing 20 days of treatment with AD to a regime of ACBT, GAD and manual techniques applied by a physiotherapist in COPD patients who produced copious amounts of sputum. Both treatment groups displayed significant improvements in lung function and gas exchange, with few differences between the groups.
Autogenic drainage is a technique based on the principle of preventing airway collapse and reducing limitation to expiratory flow.'9 As such it is likely to be of greatest use in patients who exhibit dynamic airway collapse during forced expirations. Although it is likely Chronic Respiratory Disease that dynamic airway collapse impedes airway clearance in some patients with COPD, the prevalence and physiological characteristics of such patients are unknown. Further data are required to establish how best to match the physiological principles of AD to the clinical characteristics of patients with COPD.
Which technique for which patient? Recommendations for clinical practice
Given the heterogeneity of COPD lung disease, it is likely that there is a cohort of patients who will benefit from prescription of a sputum clearance regimen. The task of the clinician is to decide which of the myriad ACTs will be most effective for each particular patient. A number of limitations in the airway clearance literature render it difficult to decide which ACT to prescribe. In particular, the use of mixed disease groups in airway clearance trials makes results difficult to interpret, given the differences in pathophysiology in diseases such as COPD, CF and bronchiectasis.28 '32,50 Additionally, many studies have failed to adequately characterize subjects with regard to the presence of bronchiectasis and the amount of sputum expectorated. Where comparison of techniques is made there has been a lack of standardization of, or a failure to include the FET.64,68 There has been little attention to the physiological mechanism of individual ACTs in COPD. Finally, most trials have had a short follow-up, giving little guidance with regard to longer-term efficacy in COPD. Despite these limitations, the literature does suggest some factors which should be taken into consideration when prescribing ACTs in COPD. We propose the following recommendations, based on available evidence and clinical experience.
Prescription of ACTs should be based on the individual's underlying pattern of lung disease. Airway clearance techniques may be more effective in COPD patients who have bronchiectasis.8'28'29 However, patients with bronchiectasis may be clinically indistinguishable from other patients with COPD unless high resolution computed tomography has been performed.11 In addition, the effect of lung recoil pressure may determine the choice of ACTwhereas the ACBT may be effective for those with normal lung recoil pressure, the forced expirations may result in airway collapse in patients with reduced recoil pressure. Alternative techniques which are not reliant on forced expirations are more appropriate in such patients, who are characterized by higher compliance and lung hyperinflation on respiratory function testing.
Strong evidence exists that CCPT should only be applied to those COPD patients who produce copious amounts of pulmonary secretions, defined as greater than 30 mL/day.28 '29,54 At present there is no evidence that percussion and vibration are effective in COPD and therefore these should not be a routine component of CCPT. Where GAD is to be used, the patient's age and comorbidites should be considered. Those with significant osteoarthritis may find GAD uncomfort-able28 and HDT positions are likely to be inappropriate in those with GOR.44 In addition, those with severe airflow obstruction may not tolerate HDT positions due to increased work of breathing and dyspnoea. 23 In such cases alternative techniques should be considered. Sidelying positions without HDT have been shown to reduce dyspnoea in patients with copious secretions. 71 Techniques that can be performed in upright positions, such as PEP therapy, should also be considered.
For patients with smaller amounts of sputum (less than 30 mL/day), the ACBT may be an appropriate choice.'3 56 The ACBT can also be used effectively by those who produce copious secretions59 and thus provides an alternative to CCPT that can be used in sidelying or sitting positions. Care should be taken to provide appropriate coaching in the FET, as the success of airway clearance is likely to depend on the patient's skill in performing forced expirations. The therapist should be vigilant to avoid dynamic airway collapse during FET,13 which may be indicated by nonproductive huffing and a characteristic 'wheezing' sound, as this appears to occur not infrequently in COPD. It may be possible to modify the FET in order to prevent dynamic airway collapse; particularly by decreasing expiratory force or increasing lung volume. Alternatively, AD could be consideredalthough it has received scant attention in COPD, it may very useful for those patients in whom forced expirations are ineffective.
Positive expiratory pressure therapy is a promising ACT for patients with COPD, with encouraging results in one long-term trial.62 An important effect of PEP in COPD may be the use of mouth pressure to splint open collapsible airways'9 and it should be trialed in patients where airway collapse during the FET is suspected. Given that ACTs which rely on forced expirations are unlikely to be effective in patients with reduced elastic recoil,'3 PEP therapy is well suited to patients with demonstrated increase in pulmonary compliance or marked pulmonary hyperinflation. Clinical experience indicates that mouthpiece PEP may be better tolerated than mask PEP in patients with COPD due to claustrophobia and the increased deadspace associated with the mask. A simple method of providing PEP has been described using a plastic bottle with 5-15 cm of water and a length of flexible tubing.72 This form of underwater PEP is cheap and can be easily provided to patients. At present no data exist to guide the clinician in deciding between oscillating or nonoscillating forms of PEP and individual preferences of patients and clinicians are likely to be important.
Airway clearance needs should be re-evaluated during acute exacerbations of COPD, when amounts of sputum are likely to be increased4 and work of breathing issues may be a more important consideration. Both the ACBT57 and PEP therapy63 can be used effectively in COPD patients with acute respiratory failure requiring NIV. Whereas use of PEP therapy requires that the patient be removed from the ventilator, it is possible to use the ACBT in NIV-dependent patients if specific training is given. 73 Once the exacerbation has resolved, the need for ongoing ACTs should be assessed.
In conclusion, the heterogeneity of lung disease in COPD makes it unlikely that there is one 'best' ACT for all patients. The needs of individual patients for regular airway clearance should be evaluated, taking into consideration the nature of the underlying lung disease, the amount of sputum produced, and the effects of ACTs on lung volumes, expiratory flow and dynamic airway compression in each patient. Acceptability of ACTs to patients should also be considered, especially where long-term adherence is required. Further investigation of ACTs should focus on more appropriate matching of the physiological effects of individual ACTs to the pathophysiology of lung disease in COPD.
